Skip to main content

Nonprofit · EIN 22-3369741

INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC

Tax-exempt · LAWRENCEVILLE, NJ 08648

Financials

$18.5M$17.2M2023$19.7M$19.4M2024
Revenue Expenses · by fiscal year end
Financials of INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$19,723,828$19,363,160$360,668$30,224,428$4,613,950$25,610,478
December 31, 2023990$18,483,761$17,227,897$1,255,864$27,237,931$2,891,022$24,346,909
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$0
Program service revenue
$18,544,488
Investment income
$1,107,744
Net rental income
$64,719
Net gain from sales of assets
$381,120
Other revenue
$71,596

Expenses

Grants and similar amounts paid
$0
Compensation of officers, directors and key employees
$346,150
Other salaries and wages
$7,477,863
Salaries, compensation and benefits (total)
$9,249,275
Professional fundraising fees
$0
Legal fees
$87,249
Accounting fees
$141,803
Occupancy
$96,528
Depreciation
$276,012
Program services (functional)
$16,260,823
Management and general (functional)
$3,102,337

Balance sheet and other

Total assets, start of year
$27,237,931
Total assets, end of year
$30,224,428
Total liabilities, end of year
$4,613,950
Net assets, end of year
$25,610,478
Land, buildings and equipment
$2,608,507
Publicly traded securities
$21,953,497
Net assets without donor restrictions
$25,610,478
Gross unrelated business income
$4,000
Gross receipts
$24,290,445
Employees
69
Volunteers
1,000
Year formed
1995
State of legal domicile
NJ

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
SUSAN CAPONCHIEF OPERATING OFFICER
Officer
40$317,919$28,231
LAURA PIZZICHIEF SCIENCE OFFICER
Highest-paid employee
40$318,549$12,273
ELIZABETH LANECHIEF MARKETING OFFICER
Highest-paid employee
40$233,634$31,859
SEAN GORMLEYDIRECTOR, BUSINESS DEVELOPMENT
Highest-paid employee
40$222,811$36,692
CHANTAL ALMONORDCHIEF INFO & ENGAGEMENT OFFICER
Highest-paid employee
40$201,641$34,293
PAUL WONGDIRECTOR, GLOBAL EVENTS
Highest-paid employee
40$204,550$21,913
EBERECHUKWU ONUKWUGHA MS PHDPRESIDENT (SINCE JUNE 2024)
Trustee or director, Officer
2$0$0
UWE SIEBERT MD MP SCDPRESIDENT-ELECT
Trustee or director, Officer
2$0$0
BRIAN O'ROURKEPAST PRESIDENT (SINCE JUNE 2024)
Trustee or director, Officer
2$0$0
SEAN SULLIVAN MSC PHDTREASURER
Trustee or director, Officer
2$0$0
AMY K O'SULLIVAN PHDDIRECTOR
Trustee or director
2$0$0
RAMIRO GILARDINO MD MHSDIRECTOR
Trustee or director
2$0$0
DALIA DAWOUD PHDDIRECTOR
Trustee or director
2$0$0
DANIEL OLLENDORF PHDDIRECTOR
Trustee or director
2$0$0
ELISABETH FENWICK PHD MSCDIRECTOR
Trustee or director
2$0$0
7 more people on this return
NameTitleHours / weekCompensation
KATJA RUDELL PHD MSCDIRECTOR
Trustee or director
2$0
LUCINDA ORSINI DPM MPHDIRECTOR
Trustee or director
2$0
BETH DEVINE PHDDIRECTOR (UNTIL 06/24)
Trustee or director
2$0
MARLENE GYLDMARK MPHILDIRECTOR (UNTIL 06/24)
Trustee or director
2$0
ANDREA MANCA MSC PHDDIRECTOR (UNTIL 06/24)
Trustee or director
2$0
DONG-CHURL SUH PHDDIRECTOR (UNTIL 06/24)
Trustee or director
2$0
JAN ELIAS HANSEN PHDPAST PRESIDENT (UNTIL JUNE 2024)
Trustee or director, Officer
2$0
990 for the year ended December 31, 2023: 22 people
NameTitleHours / weekCompensationOther / benefits
SUSAN CAPONCHIEF OPERATING OFFICER
Officer
40$380,503$30,305
LAURA PIZZICHIEF SCIENCE OFFICER
Highest-paid employee
40$300,058$56,881
NANCY S BERGCEO & EXECUTIVE DIRECTOR
Trustee or director, Officer
40$257,968$20,944
ELIZABETH LANECHIEF MARKETING OFFICER
Highest-paid employee
40$215,462$25,527
JENNIFER OLSEN-CASILLASDIRECTOR, MEMBER ENGAGEMENT
Highest-paid employee
40$199,150$34,540
MICHELLE ROVNERDIRECTOR, MARKETING
Highest-paid employee
40$190,242$34,005
PAUL WONGDIRECTOR, GLOBAL EVENTS
Highest-paid employee
40$197,764$11,866
JILL CHENDIRECTOR, FINANCE AND ACCOUNTING
Officer
40$155,317$42,423
JAN ELIAS HANSON PHDPAST PRESIDENT (SINCE JULY 2023)
Trustee or director, Officer
2$0$0
BRIAN O'ROURKEPRESIDENT (SINCE JULY 2023)
Trustee or director, Officer
2$0$0
SEAN SULLIVAN MSC PHDTREASURER
Trustee or director, Officer
2$0$0
DAVID THOMPSON PHDDIRECTOR (UNTIL 6/30/23)
Trustee or director
2$0$0
EBERECHUKWU ONUKWUGHA MS PHDPRESIDENT-ELECT (SINCE JULY 2023)
Trustee or director, Officer
2$0$0
BETH DEVINE PHDDIRECTOR
Trustee or director
2$0$0
MARLENE GYLDMARK MPHILDIRECTOR
Trustee or director
2$0$0
ANDREA MANCA MSC PHDDIRECTOR
Trustee or director
2$0$0
DONG-CHURL SUH PHDDIRECTOR
Trustee or director
2$0$0
LOTTE STEUTEN MPHILDIRECTOR (UNTIL 6/30/23)
Trustee or director
2$0$0
DALIA DAWOUD PHDDIRECTOR
Trustee or director
2$0$0
AMY K O'SULLIVAN PHDDIRECTOR
Trustee or director
2$0$0
LUCINDA ORSINI DPM MPHDIRECTOR
Trustee or director
2$0$0
ISAO KAMEPRESIDENT TO 7/1/23 THEN PAST PRESIDENT
Trustee or director
2$0$0

Address and contacts

Address (IRS master file)
505 LAWRENCE SQUARE BLVD S, LAWRENCEVILLE, NJ 08648-2675
In care of
% MARILYN SMITH
Principal officer (990 for 2024)
KATE TARPEY, 505 LAWRENCE SQUARE BLVD SOUTH, LAWRENCEVILLE, NJ 08648
Signed the 990
KATE TARPEY, CHIEF FINANCIAL OFFICER
Phone
(609) 586-4981
Return prepared by
BAKER TILLY ADVISORY GROUP LP

Mission

THE MISSION OF INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS OUTCOMES RESEARCH (ISPOR) IS TO PROMOTE HEALTH ECONOMICS AND OUTCOMES RESEARCH EXCELLENCE TO IMPROVE DECISION MAKING FOR HEALTH GLOBALLY.

990 for the year ended December 31, 2024

Program accomplishments

  • ISPOR IS A GLOBAL, NONPROFIT SCIENTIFIC AND EDUCATIONAL SOCIETY ADVANCING EXCELLENCE IN HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) TO IMPROVE HEALTHCARE DECISION-MAKING WORLDWIDE.ISPOR HAS OVER 18,000 INVIDIVIDUAL AND CHAPTER MEMBERS ACROSS MORE THAN 100 COUNTRIES WHO ARE INVOLVED IN HEALTHCARE ECONOMICS AND OUTCOMES RESEARCH, INCLUDING STAKEHOLDERS FROM ACADEMIA, GOVERNMENT, PAYERS, INDUSTRY, HEALTHCARE PROVIDERS, AND PATIENT ORGANIZATIONS.ISPOR FOSTERS THE USE OF HEALTH ECONOMICS AND OUTCOMES RESEARCH FOR HEALTHCARE POLICY AND DECISION-MAKING WORLDWIDE WITH OVER 75 REGIONAL CHAPTERS AND NEARLY 100 STUDENT NETWORKS ACROSS THE GLOBE. THROUGH TASK FORCES, COUNCILS, AND SPECIAL INTEREST GROUPS, ISPOR ALSO DEVELOPS CONSENSUS GUIDELINES ON OUTCOMES RESEARCH METHODS AND THE APPLICATION OF THIS RESEARCH IN HEALTHCARE DECISIONS. THE ISPOR GOOD PRACTICES REPORTS ARE HIGHLY CITED, EXPERT CONSENSUS GUIDANCE RECOMMENDATIONS THAT SET INTERNATIONAL STANDARDS FOR HEOR AND ITS USE IN HEALTHCARE DECISION MAKING. OTHER ISPOR REPORTS AND RESEARCH TOOLS PROVIDE GUIDANCE ON IMPORTANT AREAS SUCH AS HTA, HEALTH POLICY, AI AND REAL-WORLD EVIDENCE. THESE RESOURCES ARE WIDELY USED WITH OVER 1,000,000 DOWNLOADS ANNUALLY.ISPOR PUBLISHES THREE SCIENTIFIC JOURNALS AND MULTIPLE NEWSLETTERS TO ADVANCE THE FIELD OF HEALTH ECONOMICS AND OUTCOMES RESEARCH AND HELP HEALTHCARE LEADERS MAKE EVIDENCE-BASED DECISIONS. IN 2024, THE SOCIETY PUBLISHED 5 NEW ISPOR REPORTS IN ITS JOURNAL VALUE IN HEALTH AND PROVIDED EDUCATIONAL EXCELLENCE THROUGH INITIATIVES LIKE THE HEOR LEARNING LAB, SHORT COURSES, AND WEBINARS.ISPOR'S ANNUAL CONFERENCES AND SUMMITS PROVIDE A FORUM TO FACILITATE THE INTERCHANGE OF SCIENTIFIC KNOWLEDGE IN HEALTH ECONOMICS AND OUTCOMES RESEARCH AND ITS USE IN HEALTHCARE POLICY AND DECISION-MAKING. IN 2024, ISPOR HOSTED INTERNATIONAL CONFERENCES IN ATLANTA AND BARCELONA WITH A RECORD ATTENDANCE OVER 10,000 ATTENDEES.
    Expenses $16,260,823 · revenue $18,450,488

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Check at the IRS
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
22-3369741
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1995
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H02)
Assets (IRS master file)
$31,193,981
Income (IRS master file)
$33,565,143

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$19,723,828$19,363,160$30,224,428XML
990-TDecember 2024–––IRS
990December 2023$18,483,761$17,227,897$27,237,931XML
990-TDecember 2023–––IRS
990December 2022$14,593,000$15,156,974$23,939,884IRS
990-TDecember 2022–––IRS
990December 2021–––IRS
990-TDecember 2021–––IRS
990December 2020–––IRS
990-TDecember 2020–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 22-3369741).

Questions about INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC

What is the EIN of INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC?
The employer identification number (EIN) of INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC is 22-3369741.
Is INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1995.
Are donations to INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC due?
The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
When did INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC?
The 990 for the year ended December 31, 2024 names KATE TARPEY.
Who are the officers and directors of INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC?
The 990 for the year ended December 31, 2024 lists 22 people; 6 received compensation from the organization, the highest $317,919 (SUSAN CAPON, CHIEF OPERATING OFFICER).
How much revenue does INTL SOCIETY OF PHARMACOECONOMICS AND OUTCOMES RESEARCH INC have?
On its 990 for the year ended December 31, 2024 it reported revenue of $19,723,828, expenses of $19,363,160 and total assets of $30,224,428 at year end.

Other nonprofits in LAWRENCEVILLE

All nonprofits in LAWRENCEVILLE · New Jersey · Medical research